Literature DB >> 1656611

Hepatitis C virus. A review.

E Tang1.   

Abstract

Hepatitis C virus has been shown to be responsible for most cases of posttransfusion hepatitis, as well as for sporadic non-A, non-B viral hepatitis. Hepatitis C virus has also been implicated in the development of primary hepatocellular carcinoma, autoimmune hepatitis, and fulminant viral hepatitis. Although the role of the parenteral transmission of hepatitis C virus is well established, its route of transmission in cases of sporadic infection remains unclear. Sexual transmission is suspected but not confirmed. Recent work regarding treatment has shown interferon alfa to be effective, but the discontinuation of therapy is associated with a 50% relapse rate.

Entities:  

Mesh:

Year:  1991        PMID: 1656611      PMCID: PMC1002947     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  38 in total

1.  Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers.

Authors:  J E Everhart; A M Di Bisceglie; L M Murray; H J Alter; J J Melpolder; G Kuo; J H Hoofnagle
Journal:  Ann Intern Med       Date:  1990-04-01       Impact factor: 25.391

2.  Tests help nail down HCV--but not entirely.

Authors:  P Cotton
Journal:  JAMA       Date:  1991-01-16       Impact factor: 56.272

3.  Hepatitis C virus transmitted by human bite.

Authors:  G M Dusheiko; M Smith; P J Scheuer
Journal:  Lancet       Date:  1990-08-25       Impact factor: 79.321

4.  Anti-HCV testing in autoimmune hepatitis and primary biliary cirrhosis.

Authors:  M Fusconi; M Lenzi; G Ballardini; R Miniero; F Cassani; D Zauli; F B Bianchi
Journal:  Lancet       Date:  1990-09-29       Impact factor: 79.321

5.  Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV).

Authors:  U Hopf; B Möller; D Küther; R Stemerowicz; H Lobeck; A Lüdtke-Handjery; E Walter; H E Blum; M Roggendorf; F Deinhardt
Journal:  J Hepatol       Date:  1990-01       Impact factor: 25.083

Review 6.  Hepatitis C virus and transfusion transmitted liver disease: review.

Authors:  J C Underwood
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

Review 7.  Clinical presentation of acute viral hepatitis.

Authors:  N McIntyre
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

Review 8.  Fulminant viral hepatitis.

Authors:  E A Fagan; R Williams
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

9.  Hepatitis C virus antibodies among risk groups in Spain.

Authors:  J I Esteban; R Esteban; L Viladomiu; J C López-Talavera; A González; J M Hernández; M Roget; V Vargas; J Genescà; M Buti
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

10.  Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

Authors:  I G McFarlane; H M Smith; P J Johnson; G P Bray; D Vergani; R Williams
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.